Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1

被引：0

作者：

Tsementzi, D. ^{[1
]}

Buchwald, Z. S. ^{[2
]}

Qiu, L. ^{[3
]}

Khan, M. K. ^{[1
]}

Konstantinidis, K. ^{[4
]}

Bruner, D. W. ^{[5
]}

Lin, J. Y., Jr. ^{[6
,7
]}

机构：

[1] Emory Univ, Atlanta, GA 30322 USA

[2] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA

[3] Emory Univ, Atlanta, GA 30322 USA

[4] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA

[5] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA

[6] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA

[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.969

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3552

引用

页码：E667 / E667

页数：1

共 50 条

[21] Pulmonary Sarcoidosis Associated With Anti-Pd-L1 Therapy
Balestra, R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[22] Anti-PD-L1 therapy: patient selection is important
Peter Sidaway
Nature Reviews Clinical Oncology, 2016, 13 (3) : 134 - 134
[23] Product review on the Anti-PD-L1 antibody atezolizumab
Shah, Neil J.
Kelly, William J.
Liu, Stephen V.
Choquette, Karin
Spira, Alexander
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 269 - 276
[24] Anti-PD-L1 peptide improves survival in sepsis
Shindo, Yuichiro
McDonough, Jacquelyn S.
Chang, Katherine C.
Ramachandra, Murali
Sasikumar, Pottayil G.
Hotchkiss, Richard S.
JOURNAL OF SURGICAL RESEARCH, 2017, 208 : 33 - 39
[25] Suppression of Endometriosis Using Anti-PD-L1 Antibody
Mamillapalli, Ramanaiah
Gawde, Nimisha
Ucar, Abdullah
Taylor, Hugh S.
REPRODUCTIVE SCIENCES, 2023, 30 : 198A - 199A
[26] Product review: avelumab, an anti-PD-L1 antibody
Collins, Julie M.
Gulley, James L.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 891 - 908
[27] Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies
Petit, P-F.
Zhu, J.
van den Eynde, B. J.
ANNALS OF ONCOLOGY, 2020, 31 : S1425 - S1425
[28] The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Peng, Zhi
Cheng, Siyuan
Kou, Yan
Wang, Ziqi
Jin, Rong
Hu, Han
Zhang, Xiaotian
Gong, Ji-fang
Li, Jian
Lu, Ming
Wang, Xicheng
Zhou, Jun
Lu, ZhiHao
Zhang, Quan
Tzeng, David T. W.
Bi, Dongtao
Tan, Yan
Shen, Lin
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (10) : 1251 - 1261
[29] ANTI-PD-1 AND ANTI-PD-L1 ANTIBODIES AS IMMUNOTHERAPY AGAINST CANCER: A STRUCTURAL PERSPECTIVE
Cordova-Bahena, Luis
Velasco-Velazquez, Marco A.
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (01): : 8 - 16
[30] Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
Kathryn Lurain
Ramya Ramaswami
Robert Yarchoan
Thomas S. Uldrick
Current HIV/AIDS Reports, 2020, 17 : 547 - 556

← 1 2 3 4 5 →